PT  - JOURNAL ARTICLE
AU  - Overman, Michael
AU  - Javle, Milind
AU  - Davis, Richard E
AU  - Vats, Pankaj
AU  - Kumar-Sinha, Chandan
AU  - Xiao, Lianchun
AU  - Mettu, Niharika B
AU  - Parra, Edwin R
AU  - Benson, Al B
AU  - Lopez, Charles D
AU  - Munugalavadla, Veerendra
AU  - Patel, Priti
AU  - Tao, Lin
AU  - Neelapu, Sattva
AU  - Maitra, Anirban
TI  - Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancer
AID  - 10.1136/jitc-2020-000587
DP  - 2020 Feb 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e000587
VI  - 8
IP  - 1
4099  - http://jitc.bmj.com/content/8/1/e000587.short
4100  - http://jitc.bmj.com/content/8/1/e000587.full
SO  - J Immunother Cancer2020 Feb 01; 8
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.